Form 4 for LUNG Pulmonx Corp
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008639 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | A - Grant | $0.00 | +205.3K | 205.3K | New | $0 |
| D | 2024-03-19 | 2024-03-15 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | A - Grant | $0.00 | +425.1K | 425.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 205,286 | $0.00 | 205,286 | D | — | — | (F1) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest in accordance with the following schedule: 25% vests on March 3, 2025, and the remainder of the award vests in equal quarterly installments over the subsequent three-year period. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-03-15 | A | A | 425,116 | $0.00 | 425,116 | D | $8.95 · — to 2034-03-14 | 425,116 Common Stock | (F2) Twenty-five percent of the shares subject to the option vests on March 3, 2025, and the remainder vests in equal monthly installments over the subsequent three-year period. |